Steven Yatomi-Clarke
Chief Executive Officer, Managing Director / Prescient Therapeutics
Steven Yatomi-Clarke has a strong track record of financing multiple private and public biotechnology companies. Mr Yatomi-Clarke holds more than 15 years’ experience in investment banking with a particular focus on the life sciences/biotechnology sector.